Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Net Margin (2022 - 2023)

Historic Net Margin for Pasithea Therapeutics (KTTA) over the last 2 years, with Q2 2023 value amounting to 47.48%.

  • Pasithea Therapeutics' Net Margin rose 34024500.0% to 47.48% in Q2 2023 from the same period last year, while for Mar 2024 it was 1162.39%, marking a year-over-year decrease of 6300800.0%. This contributed to the annual value of 453.92% for FY2022, which is 139765800.0% up from last year.
  • According to the latest figures from Q2 2023, Pasithea Therapeutics' Net Margin is 47.48%, which was up 34024500.0% from 455.8% recorded in Q1 2023.
  • In the past 5 years, Pasithea Therapeutics' Net Margin ranged from a high of 455.8% in Q1 2023 and a low of 3449.93% during Q2 2022